Evidence map›Paper›PMID 33202040›Full record

SynthesisSpecial care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry2020

Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Susanne Krämer, James Lucas, Francisca Gamboa, Miguel Peñarrocha Diago, David Peñarrocha Oltra, Marcelo Guzmán-Letelier, Sanchit Paul, Gustavo Molina, Lorena Sepúlveda, Ignacio Araya and 12 more

Registry-linked trialOpen access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05288478 (Phase II Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in Epidermolysis Bullosa.), which is not on this map. Cited by 32 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 5 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05288478 phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

Phase II Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in Epidermolysis Bullosa.

TypeinterventionalSponsorUniversity of ChileRan2022 to 2023Enrolled100ConditionsEpidermolysis Bullosa, Oral UlcerArmsDentoxol mouthrinse dosages
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry · 2020
    Pooled it
  5. Orthodontic Treatment in Patients With Epidermolysis Bullosa (EB)-Clinical Practice Guidelines (CPG).Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Guideline
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 9 countries.

Susanne KrämerFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0002-8510-4022
James LucasDental Department, Royal Children's Hospital, Melbourne, Australia.
Francisca GamboaFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0002-2301-6502
Miguel Peñarrocha DiagoStomatology Department, Faculty of Medicine and Dentistry, University of Valencia, Spain.
David Peñarrocha OltraStomatology Department, Faculty of Medicine and Dentistry, University of Valencia, Spain.
Marcelo Guzmán-LetelierHospital Base Valdivia, Valdivia, Chile.
Sanchit PaulNurturing Healthy Smiles, Greater Noida, India.
Gustavo MolinaUniversidad Nacional de Córdoba, Argentina.ORCID https://orcid.org/0000-0002-9244-7306
Lorena SepúlvedaFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0002-4868-9367
Ignacio ArayaFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0003-2333-5033
Rubén SotoFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0002-2055-2641
Carolina ArriagadaFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0001-7167-1598
Anne W LuckyCincinnati Children's Epidermolysis Bullosa Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Jemima E MellerioSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Roger CornwallCincinnati Children's Epidermolysis Bullosa Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Fatimah AlsayerRoyal National ENT and Eastman Dental Hospitals, University College London Hospitals, London, UK.
Reinhard SchilkeHannover Medical School, Department of Conservative Dentistry, Periodontology and Preventive Dentistry, Hannover, Germany.
Mark Adam AntalUniversity of Szeged, Faculty of Dentistry, Szeged, Hungary.
Fernanda CastrillónFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0003-2783-3830
Camila ParedesFacultad de Odontología, Universidad de Chile, Santiago, Chile.ORCID https://orcid.org/0000-0001-9817-3249
Maria Concepción SerranoPrivate practice, Valencia, Spain.
Victoria ClarkBirmingham Children's Hospital, UK.
University of Chile · CLCincinnati Children's Hospital Medical Center · USUniversitat de València · ESBirmingham Children's Hospital · GBGuy's and St Thomas' NHS Foundation Trust · GBHospital Santiago Oriente - Dr. Luis Tisne Brousse · CLInstituto Valenciano de la Edificación · ESIQVIA (India) · INMedizinische Hochschule Hannover · DERoyal Children's Hospital · AUSan Sebastián University · CLUniversidad Católica de Córdoba · ARUniversity of Szeged · HUUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInherited epidermolysis bullosa (EB) is a genetic disorder characterized by skin fragility and unique oral features.

aimsTo provide (a) a complete review of the oral manifestations in those living with each type of inherited EB, (b) the current best practices for managing oral health care of people living with EB, (c) the current best practices on dental implant-based oral rehabilitation for patients with recessive dystrophic EB (RDEB), and (d) the current best practice for managing local anesthesia, principles of sedation, and general anesthesia for children and adults with EB undergoing dental treatment.

methodsSystematic literature search, panel discussion including clinical experts and patient representatives from different centers around the world, external review, and guideline piloting.

resultsThis article has been divided into five chapters: (i) general information on EB for the oral health care professional, (ii) systematic literature review on the oral manifestations of EB, (iii) oral health care and dental treatment for children and adults living with EB-clinical practice guidelines, (iv) dental implants in patients with RDEB-clinical practice guidelines, and (v) sedation and anesthesia for adults and children with EB undergoing dental treatment-clinical practice guidelines. Each chapter provides recommendations on the management of the different clinical procedures within dental practice, highlighting the importance of patient-clinician partnership, impact on quality of life, and the importance of follow-up appointments. Guidance on the use on nonadhesive wound care products and emollients to reduce friction during patient care is provided.

conclusionsOral soft and hard tissue manifestations of inherited EB have unique patterns of involvement associated with each subtype of the condition. Understanding each subtype individually will help the professionals plan long-term treatment approaches.

Indexed as

Anesthesia, DentalEpidermolysis BullosaEpidermolysis Bullosa DystrophicaAdultChildHumansOral HealthPractice Guidelines as TopicQuality of Lifeclinical practice guidelinedental implantsdental treatmentdystrophic epidermolysis bullosaepidermolysis bullosaepidermolysis bullosa simplexgeneral anesthesiajunctional epidermolysis bullosakindler epidermolysis bullosaoral careoral rehabilitationrecessive dystrophic epidermolysis bullosasedation

Identifiers

PMID33202040
PMCPMC7756753
OpenAlexW3101096940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.